Huntington National Bank’s Edwards Lifesciences Corp Position
Does Huntington National Bank own Edwards Lifesciences Corp (EW)? Yes — 136.2K shares worth $11M (+0.06% of its 13F portfolio) as of Q1 2026, down from 146.7K shares the prior filed quarter.
Position Value
$11M
Q1 2026
Shares
136.2K
% of Portfolio
+0.06%
Quarters Held
30
currently held
Position History EW
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 136.2K | $11M | +0.06% |
| Q4 2025 | 146.7K | $13M | +0.08% |
| Q3 2025 | 151.4K | $12M | +0.07% |
| Q2 2025 | 165.4K | $13M | +0.08% |
| Q1 2025 | 173.9K | $13M | +0.09% |
| Q4 2024 | 194.9K | $14M | +0.10% |
| Q3 2024 | 221.1K | $15M | +0.11% |
| Q2 2024 | 242.1K | $22M | +0.17% |
| Q1 2024 | 253.6K | $24M | +0.20% |
| Q4 2023 | 277.4K | $21M | +0.19% |
| Q3 2023 | 306.1K | $21M | +0.21% |
| Q2 2023 | 325.2K | $31M | +0.28% |
| Q1 2023 | 341.9K | $28M | +0.28% |
| Q4 2022 | 398.0K | $30M | +0.31% |
| Q3 2022 | 640.0K | $53M | +0.60% |
| Q2 2022 | 766.0K | $73M | +0.78% |
| Q1 2022 | 818.3K | $96M | +0.89% |
| Q4 2021 | 807.2K | $105M | +0.95% |
| Q3 2021 | 783.4K | $89M | +0.89% |
| Q2 2021 | 772.4K | $80M | +0.80% |
| Q1 2021 | 770.8K | $64M | +0.78% |
| Q4 2020 | 759.4K | $69M | +0.91% |
| Q3 2020 | 801.4K | $64M | +0.93% |
| Q2 2020 | 803.5K | $56M | +0.88% |
| Q1 2020 | 290.3K | $55M | +1.03% |
| Q4 2019 | 310.6K | $72M | +1.09% |
| Q3 2019 | 304.4K | $67M | +1.08% |
| Q2 2019 | 309.2K | $57M | +0.92% |
| Q1 2019 | 292.5K | $56M | +0.92% |
| Q4 2018 | 285.0K | $44M | +0.78% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Huntington National Bank’s full portfolio or all institutional holders of EW.